ZURA Stock Price
Zura Bio Limited
ZURA stock price is $3.88 (-9.35% on the day), giving Zura Bio Limited a market cap of $371.82M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
ZURA Stock Overview
- Price
- $3.88
- Previous close
- $4.28
- Open
- $4.30
- Market cap
- $371.82M
- P/E ratio
- -5.4
- 52-week range
- $3.15 - $7.44
- 1-year price target
- $18.83
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSC
- MarketXLS Rank
- 42
About Zura Bio Limited
Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. The company develops Tibulizumab, an immunoglobulin G-single-chain variable fragment bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes interleukin (IL)-17A and B-cell activating factor, which is in Phase 2 clinical trial development; Crebankitug (ZB-168), a monoclonal antibody that binds and neutralizes the IL-7 receptor chain that impact on diseases driven by IL-7 and thymic stromal lymphopoietin immune pathways; and Torudokimab (ZB-880), a monoclonal antibody that neutralizes IL-33. Zura Bio Limited was founded in 2021 and is based in Henderson, Nevada.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ZURA | $3.88 | -9.3% | 4.91M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |